MX374244B - Compuesto de fosforamidato de nucleosido novedoso y su uso. - Google Patents
Compuesto de fosforamidato de nucleosido novedoso y su uso.Info
- Publication number
- MX374244B MX374244B MX2015011473A MX2015011473A MX374244B MX 374244 B MX374244 B MX 374244B MX 2015011473 A MX2015011473 A MX 2015011473A MX 2015011473 A MX2015011473 A MX 2015011473A MX 374244 B MX374244 B MX 374244B
- Authority
- MX
- Mexico
- Prior art keywords
- compound
- novel nucleoside
- nucleoside phosphoramidate
- phosphoramidate compound
- stereoisomer
- Prior art date
Links
- -1 NUCLEOSIDE PHOSPHORAMIDATE COMPOUND Chemical class 0.000 title abstract 4
- 239000002777 nucleoside Substances 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 3
- 241000710781 Flaviviridae Species 0.000 abstract 2
- 239000013078 crystal Substances 0.000 abstract 2
- 208000010710 hepatitis C virus infection Diseases 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000012453 solvate Substances 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Epidemiology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310075423 | 2013-03-08 | ||
| PCT/CN2014/073004 WO2014135107A1 (zh) | 2013-03-08 | 2014-03-06 | 新的核苷氨基磷酸酯化合物及其应用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2015011473A MX2015011473A (es) | 2016-05-31 |
| MX374244B true MX374244B (es) | 2025-03-05 |
Family
ID=51462121
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015011473A MX374244B (es) | 2013-03-08 | 2014-03-06 | Compuesto de fosforamidato de nucleosido novedoso y su uso. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US9963480B2 (enExample) |
| EP (1) | EP2940031B1 (enExample) |
| JP (1) | JP6219414B2 (enExample) |
| KR (1) | KR101857337B1 (enExample) |
| CN (4) | CN108546277B (enExample) |
| AU (1) | AU2014225052B2 (enExample) |
| BR (1) | BR112015020472B1 (enExample) |
| CA (1) | CA2899763C (enExample) |
| MX (1) | MX374244B (enExample) |
| RU (1) | RU2621709C2 (enExample) |
| WO (1) | WO2014135107A1 (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2014225052B2 (en) | 2013-03-08 | 2016-11-10 | Nanjing Sanhome Pharmaceutical Co., Ltd. | Novel nucleoside phosphoramidate compound and use thereof |
| CN104761604A (zh) * | 2014-01-02 | 2015-07-08 | 江苏豪森药业股份有限公司 | 尿嘧啶核苷酸类似物及其制备方法和应用 |
| CN105315319B (zh) * | 2014-07-30 | 2020-11-20 | 南京圣和药业股份有限公司 | 丙型肝炎病毒抑制剂及其应用 |
| WO2016023522A2 (en) * | 2014-08-15 | 2016-02-18 | Merck Sharp & Dohme Corp. | Substituted phosphoramidate compounds and uses thereof |
| WO2016044243A1 (en) * | 2014-09-16 | 2016-03-24 | Achillion Pharmaceuticals, Inc. | Pyrimidine nucleoside phosphoramidate |
| CN105348342B (zh) * | 2014-09-30 | 2018-09-21 | 南京正大天晴制药有限公司 | 核苷氨基磷酸酯化合物及药物组合物和用途 |
| CN106132972B (zh) * | 2015-02-06 | 2018-08-31 | 银杏树药业(苏州)有限公司 | 用于治疗hcv感染的氨基磷酸酯 |
| CN106866737B (zh) * | 2015-12-11 | 2020-11-20 | 南京圣和药物研发有限公司 | 膦酸衍生物及其应用 |
| AU2017324939B2 (en) * | 2016-09-07 | 2021-10-14 | Atea Pharmaceuticals, Inc. | 2'-substituted-N6-substituted purine nucleotides for RNA virus treatment |
| CN108602842B (zh) * | 2016-11-02 | 2020-10-09 | 四川科伦博泰生物医药股份有限公司 | 杂环化合物及其制备方法和用途 |
| WO2018093717A1 (en) * | 2016-11-17 | 2018-05-24 | Abbvie Inc. | Compositions and methods for treating hcv infection |
| CN108218936B (zh) * | 2016-12-13 | 2022-06-07 | 南京圣和药业股份有限公司 | 联苯核苷氨基磷酸酯化合物的异构体及其无定型物 |
| CN108218940A (zh) * | 2016-12-13 | 2018-06-29 | 南京圣和药业股份有限公司 | 核苷氨基磷酸酯类化合物、其制备方法及用途 |
| CN116492363A (zh) * | 2016-12-13 | 2023-07-28 | 南京汇诚制药有限公司 | 新的核苷氨基磷酸脂化合物的组合物及其制备方法 |
| CN108218939B (zh) * | 2016-12-13 | 2022-05-17 | 南京汇诚制药有限公司 | 联苯核苷氨基磷酸酯化合物的新晶型及制备方法 |
| CN108218938B (zh) * | 2016-12-13 | 2022-06-07 | 南京圣和药业股份有限公司 | 联苯核苷氨基磷酸酯化合物的晶型及其制备方法与用途 |
| CN108218937B (zh) * | 2016-12-13 | 2022-06-07 | 南京圣和药业股份有限公司 | 核苷氨基磷酸酯类化合物的光学异构体及其应用 |
| CN108201539B (zh) * | 2016-12-16 | 2022-04-19 | 南京汇诚制药有限公司 | 联苯核苷氨基磷酸酯化合物的应用 |
| CN109419806B (zh) * | 2017-08-23 | 2023-06-20 | 南京圣和药业股份有限公司 | 抗病毒组合物及其应用 |
| CN108997426B (zh) * | 2018-07-19 | 2020-11-13 | 大连理工大学 | 靶向Hsp60的黄酮烷氧基氨基磷酸酯衍生物、制备及应用 |
| JP2022540585A (ja) | 2019-07-12 | 2022-09-16 | キャノピー グロウス コーポレイション | カンナビノイド誘導体 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020147175A1 (en) * | 2000-11-16 | 2002-10-10 | Shepard H. Michael | Synergistic ECTA compositions |
| JP5069463B2 (ja) * | 2003-04-25 | 2012-11-07 | ギリアード サイエンシーズ， インコーポレイテッド | 抗ウイルス性ホスホネート類似物 |
| WO2006065335A2 (en) | 2004-10-21 | 2006-06-22 | Merck & Co., Inc. | Fluorinated pyrrolo[2,3-d]pyrimidine nucleosides for the treatment of rna-dependent rna viral infection |
| GB0503642D0 (en) | 2005-02-22 | 2005-03-30 | Younane Paul P M | An exercise apparatus |
| WO2006116557A1 (en) | 2005-04-25 | 2006-11-02 | Genelabs Technologies, Inc. | Nucleoside compounds for treating viral infections |
| US7964580B2 (en) | 2007-03-30 | 2011-06-21 | Pharmasset, Inc. | Nucleoside phosphoramidate prodrugs |
| PA8852101A1 (es) * | 2008-12-08 | 2010-07-27 | Medivir Ab | Nucleótidos uracil ciclopropílicos |
| MX2011006891A (es) | 2008-12-23 | 2011-10-06 | Pharmasset Inc | Fosforamidatos de nucleosidos. |
| JO3027B1 (ar) * | 2009-05-14 | 2016-09-05 | Janssen Products Lp | نيوكليوسيدات يوراسيل سبيرواوكسيتان |
| SG188497A1 (en) * | 2010-09-22 | 2013-05-31 | Alios Biopharma Inc | Substituted nucleotide analogs |
| JP2014526474A (ja) * | 2011-09-12 | 2014-10-06 | アイディニックス ファーマシューティカルズ インコーポレイテッド | ウイルス感染の治療のための化合物および薬学的組成物 |
| PL2794629T3 (pl) * | 2011-12-20 | 2018-02-28 | Riboscience Llc | 2',4'-difluoro-2'-metylo-podstawione pochodne nukleozydowe jako inhibitory replikacji rna hcv |
| AU2014225052B2 (en) | 2013-03-08 | 2016-11-10 | Nanjing Sanhome Pharmaceutical Co., Ltd. | Novel nucleoside phosphoramidate compound and use thereof |
| CN104761604A (zh) | 2014-01-02 | 2015-07-08 | 江苏豪森药业股份有限公司 | 尿嘧啶核苷酸类似物及其制备方法和应用 |
-
2014
- 2014-03-06 AU AU2014225052A patent/AU2014225052B2/en active Active
- 2014-03-06 JP JP2015560536A patent/JP6219414B2/ja active Active
- 2014-03-06 EP EP14760567.9A patent/EP2940031B1/en active Active
- 2014-03-06 CA CA2899763A patent/CA2899763C/en active Active
- 2014-03-06 RU RU2015142682A patent/RU2621709C2/ru active
- 2014-03-06 KR KR1020157027466A patent/KR101857337B1/ko active Active
- 2014-03-06 US US14/764,865 patent/US9963480B2/en active Active
- 2014-03-06 MX MX2015011473A patent/MX374244B/es active IP Right Grant
- 2014-03-06 WO PCT/CN2014/073004 patent/WO2014135107A1/zh not_active Ceased
- 2014-03-06 BR BR112015020472-4A patent/BR112015020472B1/pt active IP Right Grant
- 2014-03-07 CN CN201810261317.9A patent/CN108546277B/zh active Active
- 2014-03-07 CN CN201810261269.3A patent/CN108314697B/zh active Active
- 2014-03-07 CN CN201410081865.5A patent/CN104031104B/zh active Active
- 2014-03-07 CN CN201810261299.4A patent/CN109503686B/zh active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2899763A1 (en) | 2014-09-12 |
| HK1210619A1 (en) | 2016-04-29 |
| JP6219414B2 (ja) | 2017-10-25 |
| CN108546277A (zh) | 2018-09-18 |
| BR112015020472A2 (pt) | 2020-01-28 |
| MX2015011473A (es) | 2016-05-31 |
| CA2899763C (en) | 2020-03-10 |
| WO2014135107A1 (zh) | 2014-09-12 |
| CN104031104A (zh) | 2014-09-10 |
| EP2940031A1 (en) | 2015-11-04 |
| JP2016510043A (ja) | 2016-04-04 |
| KR101857337B1 (ko) | 2018-05-11 |
| CN104031104B (zh) | 2018-04-10 |
| CN108314697B (zh) | 2021-05-07 |
| AU2014225052A1 (en) | 2015-08-20 |
| RU2621709C2 (ru) | 2017-06-07 |
| CN109503686B (zh) | 2022-03-11 |
| RU2015142682A (ru) | 2017-04-13 |
| BR112015020472B1 (pt) | 2021-01-19 |
| US9963480B2 (en) | 2018-05-08 |
| KR20150132230A (ko) | 2015-11-25 |
| CN109503686A (zh) | 2019-03-22 |
| EP2940031A4 (en) | 2016-01-27 |
| CN108546277B (zh) | 2021-05-07 |
| CN108314697A (zh) | 2018-07-24 |
| US20150361123A1 (en) | 2015-12-17 |
| AU2014225052B2 (en) | 2016-11-10 |
| EP2940031B1 (en) | 2017-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX374244B (es) | Compuesto de fosforamidato de nucleosido novedoso y su uso. | |
| CL2015003298A1 (es) | Novedosas heteroarildihidropirimidinas unidas por puentes en 6 para el tratamiento y la profilaxis de infeccion por el virus de la hepatitis b | |
| CL2016000805A1 (es) | Nucleósidos sustituidos, nucleótidos y análogos de los mismos. | |
| CL2013002939A1 (es) | Compuestos derivados de nucleosidos 2´-sustituidos , inhibidores ns5a; composicion farmaceutica que los comprende; y su uso en el tratamiento de la hepatitis c. | |
| CL2016000493A1 (es) | Inhibidores de polimerasa hcv. | |
| CL2016000153A1 (es) | Derivados de pirrolamida sustituidos con glioxamida y su uso como medicamentos para el tratamiento de la hepatitis b | |
| EA201492188A1 (ru) | Макроциклические ингибиторы вирусов flaviviridae | |
| CL2014002093A1 (es) | Compuestos derivados piperidinopirimidinicos; composicion farmaceutica que los comprende; uso en el tratamiento de infecciones viricas. | |
| BR112014030630A2 (pt) | inibidores macrocíclicos de vírus flaviviridae | |
| SMT201500148B (it) | Composizioni per uso nel trattamento di infezioni virali | |
| EA201492205A1 (ru) | Макроциклические ингибиторы вирусов flaviviridae | |
| CL2016001509A1 (es) | Formas cristalinas de los análogos de sofosbuvir antivirales | |
| EA202090547A2 (ru) | Макроциклические деаза-оксипурины для лечения вирусных инфекций | |
| MX2016006432A (es) | Tetrahidro-benzodiazepinonas. | |
| CL2015003357A1 (es) | Derivados de nucleósidos 4'-fluoro-2'-metil sustituidos | |
| BR112013002729A2 (pt) | inibidores de vírus de hepatite c | |
| EA201791903A1 (ru) | β-D-2'-ДЕЗОКСИ-2'-α-ФТОР-2'-β-C-ЗАМЕЩЕННЫЕ-2-МОДИФИЦИРОВАННЫЕ-N6-ЗАМЕЩЕННЫЕ ПУРИНОВЫЕ НУКЛЕОТИДЫ ДЛЯ ЛЕЧЕНИЯ ВЫЗВАННЫХ HCV ЗАБОЛЕВАНИЙ | |
| WO2013106689A8 (en) | Hcv ns3 protease inhibitors | |
| EA201692358A1 (ru) | Производные изоиндолина для применения в лечении вирусной инфекции | |
| CL2015003019A1 (es) | Derivados biaromáticos antibacterianos | |
| EA201590770A1 (ru) | Ингибиторы вируса гепатита с | |
| IN2014CN00572A (enExample) | ||
| PH12015502589A1 (en) | 4`-azido, 3`-deoxy-3`-fluoro substituted nucleoside derivatives | |
| EA201591456A1 (ru) | Макроциклические и бициклические ингибиторы вируса гепатита с | |
| CL2014000394A1 (es) | Uso de compuestos fenil-benzofuran-sulfamido sustituidos para el tratamiento del virus de la hepatitis c (hcv); y composicion farmaceutica que comprende a estos compuestos fenil-benzofuran-sulfamido sustituidos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |